Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
FRONTEO surges on AI drug discovery partnership with Astellas Pharma
Fronteo Inc <2158> drew heavy buying interest, breaking through its 75-day moving average resistance to reach the upper 800 yen range.
The company, which originated in legal services using proprietary natural language processing AI, has expanded horizontally into AI solutions. Its life sciences and healthcare sectors now serve as major earnings drivers.
After the close on the 16th, Fronteo announced an agreement with Astellas Pharma Inc <4503> regarding target molecule discovery. The partnership will leverage the "Drug Discovery AI Factory" to accelerate early-stage development of innovative drugs, sparking a rally in the shares.
Source: MINKABU PRESS
*Translated by generative AI. Click here for the original article.
Related Articles
Oro shares firm on plan to cancel 2.19% of outstanding shares
Bandai Namco shares firm on share cancellation announcement
SHIGA BANK shares edge higher on reported capital alliance with Senshu Ikeda
SUNCORPORATION shares rise on increased stake by ValueAct Capital
Asahi Diamond Industrial shares jump on upgraded full-year profit forecast as chip demand fuels growth
Tokyo stocks open lower on profit-taking, oil price concerns
Singapore Nikkei 225 futures open at 59,425 yen on 17th, down 150 yen
US stock market overview for 16th: Dow gains 115 points, Nasdaq hits record high for 12th consecutive day
Major International Commodity Markets on the 16th
Major European stock indices end mixed on April 16